Cambridge, MA-based C4 Therapeutics has named Andrew Phillips its chief scientific officer. Phillips was most recently an executive at the Broad Institute of MIT and Harvard, where he headed development of therapeutics. He was a chemistry professor at Yale University before that.
Sponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
